Loading…

MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex

The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifi...

Full description

Saved in:
Bibliographic Details
Published in:Pharmacological reports 2013-09, Vol.65 (5), p.1112-1123
Main Authors: Maćkowiak, Marzena, Guzik, Rafał, Dudys, Dorota, Bator, Ewelina, Wędzony, Krzysztof
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73
cites cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73
container_end_page 1123
container_issue 5
container_start_page 1112
container_title Pharmacological reports
container_volume 65
creator Maćkowiak, Marzena
Guzik, Rafał
Dudys, Dorota
Bator, Ewelina
Wędzony, Krzysztof
description The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression. Stereological counting, immunoblot analysis and confocal laser scanning microscopy. Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis. Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.
doi_str_mv 10.1016/S1734-1140(13)71469-5
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1490705577</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1734114013714695</els_id><sourcerecordid>1490705577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</originalsourceid><addsrcrecordid>eNqFkU9PHCEYh0ljU7e2H6ENR02clpc_w8zJGK3aVNtD2zNh2XdczCyMwBr99rKuevVAIOH5_YAHQr4A-wYM2u9_QQvZAEi2D-JAg2z7Rr0jM877umg7uUNmr8gu-ZjzDWMSuFAfyC6Xou810zMSr341HYNDaunvq9NjmtDhVGKiNhR7HYPP5ZD64BLajJlOy5jrSA-jLT4GGge6rEgMSC9E5WhZIk220BUuvB3plHBIsVaN1MVU8P4TeT_YMePn53mP_D_78e_korn8c_7z5PiycVJ3peGw6CxHPXRSKN5K6yRnLcd5C3LohWZMDKC0mLsFSAvoFHOsFRIHx2SPWuyR_W3vlOLtGnMxK58djqMNGNfZgOyZZkrpDaq2qEsx53phMyW_sunBADMb1-bJtdmINCDMk2ujau7r8xHreX3ua-pFbgXaLZDrVrjGZG7iOoX67Debj7ZBrIbufA1m5zG46rT-TzGL6N9oeARHTZ22</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1490705577</pqid></control><display><type>article</type><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><source>Elsevier ScienceDirect Journals</source><source>Springer Link</source><creator>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</creator><creatorcontrib>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</creatorcontrib><description>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression. Stereological counting, immunoblot analysis and confocal laser scanning microscopy. Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis. Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</description><identifier>ISSN: 1734-1140</identifier><identifier>EISSN: 2299-5684</identifier><identifier>DOI: 10.1016/S1734-1140(13)71469-5</identifier><identifier>PMID: 24399707</identifier><language>eng</language><publisher>Cham: Elsevier Urban &amp; Partner Sp. z o.o</publisher><subject>Acetylation ; Animals ; Antipsychotic Agents - pharmacology ; Chromatin Assembly and Disassembly - drug effects ; Dizocilpine Maleate - toxicity ; Drug Safety and Pharmacovigilance ; epigenetics ; Excitatory Amino Acid Antagonists - toxicity ; Gene Expression Regulation - drug effects ; histone 3 ; Histones - metabolism ; Lysine ; Male ; medial prefrontal cortex ; MK-801 ; Pharmacotherapy ; Pharmacy ; Phenotype ; Phosphorylation ; Prefrontal Cortex - drug effects ; Prefrontal Cortex - metabolism ; Protein Processing, Post-Translational - drug effects ; Psychoses, Substance-Induced - genetics ; Psychoses, Substance-Induced - metabolism ; Psychoses, Substance-Induced - prevention &amp; control ; psychosis ; Pyramidal Cells - drug effects ; Pyramidal Cells - metabolism ; pyramidal neurons ; Rats ; Rats, Wistar ; Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors ; Receptors, N-Methyl-D-Aspartate - metabolism ; Risperidone - pharmacology ; schizophrenia ; Serine ; Time Factors</subject><ispartof>Pharmacological reports, 2013-09, Vol.65 (5), p.1112-1123</ispartof><rights>2013 Institute of Pharmacology Polish Academy of Sciences</rights><rights>Maj Institute of Pharmacology, Polish Academy of Sciences 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</citedby><cites>FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1734114013714695$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3549,27924,27925,45780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24399707$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Maćkowiak, Marzena</creatorcontrib><creatorcontrib>Guzik, Rafał</creatorcontrib><creatorcontrib>Dudys, Dorota</creatorcontrib><creatorcontrib>Bator, Ewelina</creatorcontrib><creatorcontrib>Wędzony, Krzysztof</creatorcontrib><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><title>Pharmacological reports</title><addtitle>Pharmacol. Rep</addtitle><addtitle>Pharmacol Rep</addtitle><description>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression. Stereological counting, immunoblot analysis and confocal laser scanning microscopy. Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis. Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</description><subject>Acetylation</subject><subject>Animals</subject><subject>Antipsychotic Agents - pharmacology</subject><subject>Chromatin Assembly and Disassembly - drug effects</subject><subject>Dizocilpine Maleate - toxicity</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>epigenetics</subject><subject>Excitatory Amino Acid Antagonists - toxicity</subject><subject>Gene Expression Regulation - drug effects</subject><subject>histone 3</subject><subject>Histones - metabolism</subject><subject>Lysine</subject><subject>Male</subject><subject>medial prefrontal cortex</subject><subject>MK-801</subject><subject>Pharmacotherapy</subject><subject>Pharmacy</subject><subject>Phenotype</subject><subject>Phosphorylation</subject><subject>Prefrontal Cortex - drug effects</subject><subject>Prefrontal Cortex - metabolism</subject><subject>Protein Processing, Post-Translational - drug effects</subject><subject>Psychoses, Substance-Induced - genetics</subject><subject>Psychoses, Substance-Induced - metabolism</subject><subject>Psychoses, Substance-Induced - prevention &amp; control</subject><subject>psychosis</subject><subject>Pyramidal Cells - drug effects</subject><subject>Pyramidal Cells - metabolism</subject><subject>pyramidal neurons</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</subject><subject>Receptors, N-Methyl-D-Aspartate - metabolism</subject><subject>Risperidone - pharmacology</subject><subject>schizophrenia</subject><subject>Serine</subject><subject>Time Factors</subject><issn>1734-1140</issn><issn>2299-5684</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><recordid>eNqFkU9PHCEYh0ljU7e2H6ENR02clpc_w8zJGK3aVNtD2zNh2XdczCyMwBr99rKuevVAIOH5_YAHQr4A-wYM2u9_QQvZAEi2D-JAg2z7Rr0jM877umg7uUNmr8gu-ZjzDWMSuFAfyC6Xou810zMSr341HYNDaunvq9NjmtDhVGKiNhR7HYPP5ZD64BLajJlOy5jrSA-jLT4GGge6rEgMSC9E5WhZIk220BUuvB3plHBIsVaN1MVU8P4TeT_YMePn53mP_D_78e_korn8c_7z5PiycVJ3peGw6CxHPXRSKN5K6yRnLcd5C3LohWZMDKC0mLsFSAvoFHOsFRIHx2SPWuyR_W3vlOLtGnMxK58djqMNGNfZgOyZZkrpDaq2qEsx53phMyW_sunBADMb1-bJtdmINCDMk2ujau7r8xHreX3ua-pFbgXaLZDrVrjGZG7iOoX67Debj7ZBrIbufA1m5zG46rT-TzGL6N9oeARHTZ22</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Maćkowiak, Marzena</creator><creator>Guzik, Rafał</creator><creator>Dudys, Dorota</creator><creator>Bator, Ewelina</creator><creator>Wędzony, Krzysztof</creator><general>Elsevier Urban &amp; Partner Sp. z o.o</general><general>Springer International Publishing</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</title><author>Maćkowiak, Marzena ; Guzik, Rafał ; Dudys, Dorota ; Bator, Ewelina ; Wędzony, Krzysztof</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Acetylation</topic><topic>Animals</topic><topic>Antipsychotic Agents - pharmacology</topic><topic>Chromatin Assembly and Disassembly - drug effects</topic><topic>Dizocilpine Maleate - toxicity</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>epigenetics</topic><topic>Excitatory Amino Acid Antagonists - toxicity</topic><topic>Gene Expression Regulation - drug effects</topic><topic>histone 3</topic><topic>Histones - metabolism</topic><topic>Lysine</topic><topic>Male</topic><topic>medial prefrontal cortex</topic><topic>MK-801</topic><topic>Pharmacotherapy</topic><topic>Pharmacy</topic><topic>Phenotype</topic><topic>Phosphorylation</topic><topic>Prefrontal Cortex - drug effects</topic><topic>Prefrontal Cortex - metabolism</topic><topic>Protein Processing, Post-Translational - drug effects</topic><topic>Psychoses, Substance-Induced - genetics</topic><topic>Psychoses, Substance-Induced - metabolism</topic><topic>Psychoses, Substance-Induced - prevention &amp; control</topic><topic>psychosis</topic><topic>Pyramidal Cells - drug effects</topic><topic>Pyramidal Cells - metabolism</topic><topic>pyramidal neurons</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Receptors, N-Methyl-D-Aspartate - antagonists &amp; inhibitors</topic><topic>Receptors, N-Methyl-D-Aspartate - metabolism</topic><topic>Risperidone - pharmacology</topic><topic>schizophrenia</topic><topic>Serine</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Maćkowiak, Marzena</creatorcontrib><creatorcontrib>Guzik, Rafał</creatorcontrib><creatorcontrib>Dudys, Dorota</creatorcontrib><creatorcontrib>Bator, Ewelina</creatorcontrib><creatorcontrib>Wędzony, Krzysztof</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmacological reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Maćkowiak, Marzena</au><au>Guzik, Rafał</au><au>Dudys, Dorota</au><au>Bator, Ewelina</au><au>Wędzony, Krzysztof</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex</atitle><jtitle>Pharmacological reports</jtitle><stitle>Pharmacol. Rep</stitle><addtitle>Pharmacol Rep</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>65</volume><issue>5</issue><spage>1112</spage><epage>1123</epage><pages>1112-1123</pages><issn>1734-1140</issn><eissn>2299-5684</eissn><abstract>The present study investigated whether MK-801, when given in doses that cause psychomimetic effects in rats, could alter the phosphorylation of histone 3 (H3) at serine 10 (H3S10p) and the acetylation of H3 at lysine 14 (H3K14ac) in the medial prefrontal cortex (mPFC). These posttranslational modifications of H3 promote chromatin relaxation and increase the probability of gene expression. Stereological counting, immunoblot analysis and confocal laser scanning microscopy. Treatment with MK-801 (0.4mg/kg) evoked a time-dependent increase in the number of H3S10p positive nuclei in both the II/III and V/VI layers of the mPFC, reaching the peak of activation 30min after injection. MK-801 treatment (0.4mg/kg) failed to alter H3K14ac. These effects were confirmed by immunoblot analysis on tissue samples from the mPFC. Analysis of cortical cells expressing H3S10p positive nuclei revealed that constitutive and MK-801-induced expression of H3S10p was observed only in neurons and not in glia cells (H3S10p colocalized with NeuN but not with S-100β). Moreover, it has been found that H3S10p is exclusively present in pyramidal (glutamate-positive) but not in cortical GABA-ergic interneurons (GABA-positive). The effects of MK-801 can be attenuated or blocked by the neuroleptic drug risperidone. In the cortical layer II/III, risperidone was effective at doses of 0.2 and 1mg/kg, while it was only active at a dose of 1mg/kg in the V/VI layer. Again, these stereological data were confirmed by immunoblot analysis. Our results indicate that MK-801 may increase the transcriptional activity of mPFC via the activation of the epigenetic program associated with H3S10p phosphorylation during the course of experimental psychosis.</abstract><cop>Cham</cop><pub>Elsevier Urban &amp; Partner Sp. z o.o</pub><pmid>24399707</pmid><doi>10.1016/S1734-1140(13)71469-5</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1734-1140
ispartof Pharmacological reports, 2013-09, Vol.65 (5), p.1112-1123
issn 1734-1140
2299-5684
language eng
recordid cdi_proquest_miscellaneous_1490705577
source Elsevier ScienceDirect Journals; Springer Link
subjects Acetylation
Animals
Antipsychotic Agents - pharmacology
Chromatin Assembly and Disassembly - drug effects
Dizocilpine Maleate - toxicity
Drug Safety and Pharmacovigilance
epigenetics
Excitatory Amino Acid Antagonists - toxicity
Gene Expression Regulation - drug effects
histone 3
Histones - metabolism
Lysine
Male
medial prefrontal cortex
MK-801
Pharmacotherapy
Pharmacy
Phenotype
Phosphorylation
Prefrontal Cortex - drug effects
Prefrontal Cortex - metabolism
Protein Processing, Post-Translational - drug effects
Psychoses, Substance-Induced - genetics
Psychoses, Substance-Induced - metabolism
Psychoses, Substance-Induced - prevention & control
psychosis
Pyramidal Cells - drug effects
Pyramidal Cells - metabolism
pyramidal neurons
Rats
Rats, Wistar
Receptors, N-Methyl-D-Aspartate - antagonists & inhibitors
Receptors, N-Methyl-D-Aspartate - metabolism
Risperidone - pharmacology
schizophrenia
Serine
Time Factors
title MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T11%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=MK-801,%20a%20NMDA%20receptor%20antagonist,%20increases%20phosphorylation%20of%20histone%20H3%20in%20the%20rat%20medial%20prefrontal%20cortex&rft.jtitle=Pharmacological%20reports&rft.au=Ma%C4%87kowiak,%20Marzena&rft.date=2013-09-01&rft.volume=65&rft.issue=5&rft.spage=1112&rft.epage=1123&rft.pages=1112-1123&rft.issn=1734-1140&rft.eissn=2299-5684&rft_id=info:doi/10.1016/S1734-1140(13)71469-5&rft_dat=%3Cproquest_cross%3E1490705577%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-21d8a2e7f8435264ac42062eb614f937003f1573bcd14a1ec50c0634efc049e73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1490705577&rft_id=info:pmid/24399707&rfr_iscdi=true